🇺🇸 FDA
Patent

US 6551585

Use of tumor necrosis factor as an adjuvant

expired A61KA61K2039/55522A61K38/191

Quick answer

US patent 6551585 (Use of tumor necrosis factor as an adjuvant) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/55522, A61K38/191, A61K38/2006, A61K38/217